These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38890198)

  • 1. Exploring the Perception of Value in Cancer Care: A Comparison of Patients, Providers, and Payers.
    Allen CJ; Greene AC; Joseph EA; Dunung R; Knotts CM; Chalikonda S; Bartlett DL
    Ann Surg Oncol; 2024 Oct; 31(10):6364-6365. PubMed ID: 38890198
    [No Abstract]   [Full Text] [Related]  

  • 2. Correction: Exploring the Perception of Value in Cancer Care: A Comparison of Patients, Providers, and Payers.
    Allen CJ; Greene AC; Joseph EA; Dunung R; Knotts CM; Chalikonda S; Bartlett DL
    Ann Surg Oncol; 2024 Oct; 31(10):6422. PubMed ID: 39031266
    [No Abstract]   [Full Text] [Related]  

  • 3. What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of HER2/Neu testing in breast cancer.
    Trosman JR; Weldon CB; Schink JC; Gradishar WJ; Benson AB
    J Comp Eff Res; 2013 Jul; 2(4):461-77. PubMed ID: 24236686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A regional analysis of payer and provider views on cholesterol management: PCSK9 inhibitors as an illustrative alignment model.
    McCormick D; Bhatt DL; Bays HE; Taub PR; Caldwell KA; Guerin CK; Steinhoff J; Ahmad Z; Singh R; Moreo K; Carter J; Heggen CL; Sapir T
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1517-1528. PubMed ID: 33251993
    [No Abstract]   [Full Text] [Related]  

  • 5. Meeting the affordability challenges posed by orphan drugs: a survey of payers, providers, and employers.
    Lopata E; Terrone C; Gopalan A; Ladikos N; Richardson T
    J Manag Care Spec Pharm; 2021 Jun; 27(6):706-713. PubMed ID: 33586514
    [No Abstract]   [Full Text] [Related]  

  • 6. A review and characterization of the various perceptions of quality cancer care.
    Colosia AD; Peltz G; Pohl G; Liu E; Copley-Merriman K; Khan S; Kaye JA
    Cancer; 2011 Mar; 117(5):884-96. PubMed ID: 20939015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining Misaligned Incentives for Payers and Manufacturers in Value-Based Pharmaceutical Contracts.
    Kannarkat JT; Good CB; Kelly E; Parekh N
    J Manag Care Spec Pharm; 2020 Jan; 26(1):63-66. PubMed ID: 31880231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing Shared Patient Networks Across Payers.
    Trogdon JG; Weir WH; Shai S; Mucha PJ; Kuo TM; Meyer AM; Stitzenberg KB
    J Gen Intern Med; 2019 Oct; 34(10):2014-2020. PubMed ID: 30945065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Provider Identifier (NPI) planning and implementation fundamentals for providers and payers.
    Pickens S; Solak J
    J Healthc Inf Manag; 2005; 19(2):41-7. PubMed ID: 15869212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resource-based relative-value scale expansion: implications for performance and quality of care.
    Burge RT
    Clin Perform Qual Health Care; 1997; 5(1):5-10. PubMed ID: 10165000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid expansion of new oncology care delivery payment models: results from a payer survey.
    Greenapple R
    Am Health Drug Benefits; 2013 Jul; 6(5):249-56. PubMed ID: 24991361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple payers, commonality and free-riding in health care: Medicare and private payers.
    Glazer J; McGuire TG
    J Health Econ; 2002 Nov; 21(6):1049-69. PubMed ID: 12475125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. States Encouraging Value-Based Payment: Lessons From CMS's State Innovation Models Initiative.
    Kissam SM; Beil H; Cousart C; Greenwald LM; Lloyd JT
    Milbank Q; 2019 Jun; 97(2):506-542. PubMed ID: 30957292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding Payer Perspectives on Value in the Use of Pharmaceuticals in the United States.
    Brogan AP; Hogue SL; Vekaria RM; Reynolds I; Coukell A
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1319-1327. PubMed ID: 31778613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White Paper on the Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy: The Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection as an Example.
    Jackisch C; Manevy F; Frank S; Roberts N; Shafrin J
    Adv Ther; 2022 Feb; 39(2):833-844. PubMed ID: 34988876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in biologic therapies for rheumatoid arthritis: results from a survey of payers and providers.
    Greenapple R
    Am Health Drug Benefits; 2012 Mar; 5(2):83-92. PubMed ID: 24991313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in coverage and reimbursement for reproductive genetic counseling in New Jersey by multiple payers from 2010 to 2018.
    Spinosi F; Khan S; Seymour C; Ashkinadze E
    J Genet Couns; 2021 Dec; 30(6):1748-1756. PubMed ID: 34223664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are ACOs the Answer to High-Value Healthcare?
    Yeung W; Burns H; Loiacono D
    Am Health Drug Benefits; 2011 Nov; 4(7):441-50. PubMed ID: 25126368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood and marrow transplantation compensation: perspective in payer and provider relations.
    Gajewski JL; Foote M; Tietjen J; Melson B; Simmons A; Champlin RE
    Biol Blood Marrow Transplant; 2004 Jul; 10(7):427-32. PubMed ID: 15205664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the Complexity in the Design and Implementation of Bundled Payments: A Scoping Review of Key Elements From a Payer's Perspective.
    Steenhuis S; Struijs J; Koolman X; Ket J; VAN DER Hijden E
    Milbank Q; 2020 Mar; 98(1):197-222. PubMed ID: 31909852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.